Shakirat Gold-Olufadi: Five Years of Building Apheresis Services in Lagos
Shakirat Gold-Olufadi, Resident Doctor at Brookdale University Hospital and Medical Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Therapeutic Apheresis and Dialysis, adding:
“You don’t know how much work you’ve done until you put it altogether and then do an analysis of all the data. Apheresis is that procedure where an apheresis machine separates whole blood into different components of blood.
The blood components can then be used for different purposes including therapeutic apheresis such as in plasma exchange especially when treating autoimmune conditions with autoantibodies like myasthenia gravis, red cell exchange most commonly done in sickle cell patients, and stem cell collection.
Apheresis is also important in getting seperate components of the blood like platelets where you are then able to give only the needed component of the blood such as what is done in plateletpharesis.
Dr Folasade Adelekan Popoola, the CEO of Next Hematology Medicare in Lagos has shown what is possible even in a resource limited setting. Happy to have been a part of this success story from the very beginning.
We are just getting started!
Here’s our paper on the 5 year journey since apheresis was established at Next Hematology in Lagos.”
Title: Establishing an Apheresis Medicine Program in a Resource-Constrained Setting: A 5-Year Experience From Lagos, Nigeria
Authors: Folasade Adelekan-Popoola, Shakirat Gold-Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Rasheed A. Balogun
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 1, 2026, 15:44A Century of Von Willebrand Disease Awareness – EHC
-
Oct 1, 2026, 15:31Andreas Calatzis: The Power of Teamwork in Postpartum Hemorrhage
-
Oct 1, 2026, 15:09Halimat Olaniyan: The Role of Transfusion Medicine in Sickle Cell Disease Care
-
Oct 1, 2026, 14:58Samir Kumar Beura: Modern Approaches to Platelet Structure and Function
-
Oct 1, 2026, 14:39Understanding the FDA Pathway for Hematology Product Development – American Society of Hematology
-
Oct 1, 2026, 13:56Ravi C Dara: Advancing Red Cell Exchange in Sickle Cell Disease
-
Oct 1, 2026, 13:50Mateo Marin-Cuartas: What Matters After Aortic Valve Replacement in Younger Patients?
-
Oct 1, 2026, 13:17Anirban Sen Gupta: Sharing Ideas, Advancing Biomedical Innovation
-
Oct 1, 2026, 13:01Michael Honigberg: Clonal Hematopoiesis as a Driver of Aortic Valve Calcification